Search alternatives:
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a we » a web (Expand Search), a e (Expand Search), a de (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a we » a web (Expand Search), a e (Expand Search), a de (Expand Search)
-
12001
-
12002
RORγt-expressing cells attenuate cardiac remodeling after myocardial infarction
Published 2017“…Finally, the mRNA expression of RORγt, IL-17A, IL-17F and IL-23 receptor (IL-23R) mRNA and protein expression of IL-10 were decreased in RORγt<sup>+/-</sup> hearts.…”
-
12003
-
12004
-
12005
Data_Sheet_1_Expression and Functional Analysis of lncRNAs Involved in Platelet-Derived Growth Factor-BB-Induced Proliferation of Human Aortic Smooth Muscle Cells.PDF
Published 2021“…One of the upregulated lncRNAs in proliferative HASMC was HIF1A anti-sense RNA 2 (HIF1A-AS2). HIF1A-AS2 suppression decreased HASMC proliferation via the miR-30e-5p/CCND2 mRNA axis. …”
-
12006
Table_1_Expression and Functional Analysis of lncRNAs Involved in Platelet-Derived Growth Factor-BB-Induced Proliferation of Human Aortic Smooth Muscle Cells.XLS
Published 2021“…One of the upregulated lncRNAs in proliferative HASMC was HIF1A anti-sense RNA 2 (HIF1A-AS2). HIF1A-AS2 suppression decreased HASMC proliferation via the miR-30e-5p/CCND2 mRNA axis. …”
-
12007
Image_1_Expression and Functional Analysis of lncRNAs Involved in Platelet-Derived Growth Factor-BB-Induced Proliferation of Human Aortic Smooth Muscle Cells.tif
Published 2021“…One of the upregulated lncRNAs in proliferative HASMC was HIF1A anti-sense RNA 2 (HIF1A-AS2). HIF1A-AS2 suppression decreased HASMC proliferation via the miR-30e-5p/CCND2 mRNA axis. …”
-
12008
Table_2_Expression and Functional Analysis of lncRNAs Involved in Platelet-Derived Growth Factor-BB-Induced Proliferation of Human Aortic Smooth Muscle Cells.XLS
Published 2021“…One of the upregulated lncRNAs in proliferative HASMC was HIF1A anti-sense RNA 2 (HIF1A-AS2). HIF1A-AS2 suppression decreased HASMC proliferation via the miR-30e-5p/CCND2 mRNA axis. …”
-
12009
Differences in abundance of non-lipid molecules in liver of <i>Fmo5</i><sup><i>-/-</i></sup> and WT mice.
Published 2023“…Red dots are non-lipids that are significantly increased or decreased in <i>Fmo5</i><sup><i>-/-</i></sup> mice with a -log<sub>10</sub> <i>q</i> above 1.301 (<i>q</i> <0.05) (grey line). …”
-
12010
S1 Data -
Published 2024“…We analyzed SSTR in cardiac samples from patients with end-stage ischemic cardiomyopathy (ICM, n = 8) and control hearts (n = 5). …”
-
12011
-
12012
-
12013
Differences in abundance of lipid molecules in liver of <i>Fmo5</i><sup><i>-/-</i></sup> and WT mice.
Published 2023“…Red dots are lipids that are significantly increased or decreased in <i>Fmo5</i><sup><i>-/-</i></sup> mice with a -log<sub>10</sub> <i>q</i> above 1.301 (<i>q</i> <0.05) (grey line). …”
-
12014
The data of meta-analysis.
Published 2023“…</p><p>Conclusion</p><p>In conclusion, tirzeptide can significantly reduce the weight of T2DM and patient with obesity, and it is a potential therapeutic regimen for weight-loss, but we need to be vigilant about its gastrointestinal reaction.…”
-
12015
Quality assessment for risk of bias for studies.
Published 2023“…</p><p>Conclusion</p><p>In conclusion, tirzeptide can significantly reduce the weight of T2DM and patient with obesity, and it is a potential therapeutic regimen for weight-loss, but we need to be vigilant about its gastrointestinal reaction.…”
-
12016
Effect of tirzepatide vs placebo on body weight.
Published 2023“…</p><p>Conclusion</p><p>In conclusion, tirzeptide can significantly reduce the weight of T2DM and patient with obesity, and it is a potential therapeutic regimen for weight-loss, but we need to be vigilant about its gastrointestinal reaction.…”
-
12017
The results of safety in meta-analysis.
Published 2023“…</p><p>Conclusion</p><p>In conclusion, tirzeptide can significantly reduce the weight of T2DM and patient with obesity, and it is a potential therapeutic regimen for weight-loss, but we need to be vigilant about its gastrointestinal reaction.…”
-
12018
Graphs of risk of bias for studies.
Published 2023“…</p><p>Conclusion</p><p>In conclusion, tirzeptide can significantly reduce the weight of T2DM and patient with obesity, and it is a potential therapeutic regimen for weight-loss, but we need to be vigilant about its gastrointestinal reaction.…”
-
12019
General baseline of included studies.
Published 2023“…</p><p>Conclusion</p><p>In conclusion, tirzeptide can significantly reduce the weight of T2DM and patient with obesity, and it is a potential therapeutic regimen for weight-loss, but we need to be vigilant about its gastrointestinal reaction.…”
-
12020